Understanding how the widely-abused opiate drugs influence brain function requires a better understanding of how the endogenous opioid peptides normally act as neurotransmitters. During the previous cycle of this project, we established the novel finding that opioid receptor activation causes presynaptic inhibition by an increase in a delayed rectifying potassium conductance in the nerve terminal, an observation that has been recently confirmed. Opioid-induced presynaptic inhibition of neurotransmitter release is likely to be an important mode of endogenous opioid action in many regions of the brain and peripheral nervous system. Thus, the mechanism of this opioid effect and the biophysical characteristics of the potassium channel activated will be important to define. The proposal has four components: First, we propose to characterize the signal transduction events linking the opioid receptor to potassium channel in the nerve terminals synapsing on hippocampal pyramidal and dentate granule cells by using specific pharmacological antagonists and agonists. Next, we propose to identify the specific potassium channel activated in these nerve terminals by using channel-specific toxins and mouse strains having gene deletions (""""""""knock-outs"""""""") of candidate channels. Third, we propose to continue our electrophysiological studies of opioid-activated delayed rectifying potassium channels expressed in the somata of hippocampal interneurons to define the potential mechanisms linking opioid receptors to voltage-gated K channels in these more accessible regions of the opioid-responsive neuron. Finally, we propose to reconstitute the signal transduction events in a malleable model system by expressing opioid receptors, candidate potassium channels, and proposed intermediate effectors in Xenopus oocytes. Information obtained from this study will allow us to understand the events underlying an important type of opioid-induced, presynaptic inhibition of transmitter release.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004123-12
Application #
6329119
Study Section
Special Emphasis Panel (ZRG1-MDCN-4 (01))
Program Officer
Lin, Yu
Project Start
1988-03-01
Project End
2004-11-30
Budget Start
2001-01-01
Budget End
2001-11-30
Support Year
12
Fiscal Year
2001
Total Cost
$220,680
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Pirraglia, Paul A; Hampton, John M; Rosen, Allison B et al. (2011) Psychological distress and trends in healthcare expenditures and outpatient healthcare. Am J Manag Care 17:319-28
Drake, Carrie T; Chavkin, Charles; Milner, Teresa A (2007) Opioid systems in the dentate gyrus. Prog Brain Res 163:245-63
Chavkin, Charles; Sud, Sumit; Jin, Wenzhen et al. (2004) Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations. J Pharmacol Exp Ther 308:1197-203
Jin, Wenzhen; Zhang, Jianhua; Lou, Danwen et al. (2002) C-fos-deficient mouse hippocampal CA3 pyramidal neurons exhibit both enhanced basal and kainic acid-induced excitability. Neurosci Lett 331:151-4
Rogalski, S L; Chavkin, C (2001) Eicosanoids inhibit the G-protein-gated inwardly rectifying potassium channel (Kir3) at the Na+/PIP2 gating site. J Biol Chem 276:14855-60
Terman, G W; Eastman, C L; Chavkin, C (2001) Mu opiates inhibit long-term potentiation induction in the spinal cord slice. J Neurophysiol 85:485-94
Varnado-Rhodes, Y; Gunther, J; Terman, G W et al. (2000) Mu opioid analgesia and analgesic tolerance in two mouse strains: C57BL/6 and 129/SvJ. Proc West Pharmacol Soc 43:15-7
Chavkin, C (2000) Dynorphins are endogenous opioid peptides released from granule cells to act neurohumorly and inhibit excitatory neurotransmission in the hippocampus. Prog Brain Res 125:363-7
Terman, G W; Drake, C T; Simmons, M L et al. (2000) Opioid modulation of recurrent excitation in the hippocampal dentate gyrus. J Neurosci 20:4379-88
Kovoor, A; Celver, J; Abdryashitov, R I et al. (1999) Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells. J Biol Chem 274:6831-4

Showing the most recent 10 out of 45 publications